| ALN | Program | Spent | Major | Findings |
|---|---|---|---|---|
| 93.RD | Influenza Reagent Resource (2) | $33.87M | Yes | 0 |
| 93.RD | Biological and Emerging Infections Research Resources Program | $21.56M | Yes | 0 |
| 93.RD | Leidos - Management of NCI Central Repository | $10.30M | Yes | 0 |
| 93.855 | Facility High Containment | $3.61M | Yes | 0 |
| 93.360 | BARDA BSIP IDIQ | $2.25M | Yes | 0 |
| 93.855 | High Containment Facility Renovations – Pandemic Preparedness | $1.18M | Yes | 0 |
| 93.RD | In Vitro Assessment of Antimicrobial Activity | $594,682 | Yes | 0 |
| 93.RD | Comprehensive and Rapid Response Research Program | $570,170 | Yes | 0 |
| 93.855 | Generation of Mutants of Mycobacterium Tuberculosis | $147,031 | Yes | 0 |
| 93.RD | DCEG Biospecimen Activities and Assay Support | $143,168 | Yes | 0 |
| 93.855 | Alveolar Organoids Metabolomic-Driven Cultivation of Pneumocystis Species | $114,435 | Yes | 0 |
| 12.910 | DARPA AMPHORA | $94,167 | Yes | 0 |
| 93.855 | Yale Babesia R56 | $85,718 | Yes | 0 |
| 12.351 | EGR1 Regulation of Neuronal Survival Inflammation following VEEV infection | $13,168 | Yes | 0 |
| Name | Title | Type |
|---|---|---|
| KT4MLLHK99V6 | Scott Boller | Auditee |
| 7033652754 | Leslie Pine | Auditor |
| No contacts on file | ||